The brain-heart axis is a promising model for understanding cardiovascular disease risk in PTSD, highlighting the need to determine if PTSD treatments affecting this axis reduce CVD risk.
Do PTSD treatments that affect the brain-heart axis reduce the risk of cardiovascular disease?
This review proposes the brain-heart axis as a key mechanistic pathway linking PTSD to cardiovascular disease, highlighting a novel target for reducing CVD risk in this population.
Posttraumatic stress disorder (PTSD) has long been associated with a heightened risk of cardiovascular disease (CVD). A number of mechanisms have been implicated to underlie this brain-heart axis relationship, such as altered functioning of the autonomic nervous system and increased systemic inflammation. While neural alterations have repeatedly been observed in PTSD, they are rarely considered in the PTSD-CVD link. The brain-heart axis is a pathway connecting frontal and limbic brain regions to the brainstem and periphery via the autonomic nervous system and it may be a promising model for understanding CVD risk in PTSD given its overlap with PTSD neural deficits. We first provide a summary of the primary mechanisms implicated in the association between PTSD and CVD. We then review the brain-heart axis and its relevance to PTSD, as well as findings from PTSD trials demonstrating that a number of PTSD treatments have effects on areas of the brain-heart axis. Finally, we discuss sex considerations in the PTSD-CVD link. A critical next step in this study is to determine if PTSD treatments that affect the brain-heart axis (e.g., brain stimulation that improves autonomic function) also reduce the risk of CVD.
Seligowski et al. (Thu,) conducted a review in Posttraumatic stress disorder (PTSD) and cardiovascular disease (CVD). PTSD treatments affecting the brain-heart axis was evaluated. The brain-heart axis is a promising model for understanding cardiovascular disease risk in PTSD, highlighting the need to determine if PTSD treatments affecting this axis reduce CVD risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: